A combination therapy of NRCT-101 with NRCT-202 is being developed for patients with ADHD.
ADHD
A combination therapy of NRCT-101 with NRCT-202 is being developed for patients with ADHD.
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder
-
Accel Research Site-Maitland Clinical Research Unit, Maitland, Florida, United States, 32751
iRresearch Atlanta, Decatur, Georgia, United States, 30030
CenExel iRS - iResearch Savannah, Savannah, Georgia, United States, 31405
Boston Clinical Trials LLC, Boston, Massachusetts, United States, 02131
Center For Psychiatry and Behavioral Medicine, Las Vegas, Nevada, United States, 89128
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
13 Years to 17 Years
ALL
No
Neurocentria, Inc.,
Mary Miller, MS, STUDY_DIRECTOR, Neurocentria, Inc.
2025-11